Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Safe Work Procedure (SWP) EVD Blood and Body Fluid Post Exposure Protocol This document is based on the Infection Prevention & Control Management of Ebola Virus Disease (EVD) Operational Directive in conjunction with WRHA OESH THIS IS A SPECIFIC EVD POST EXPOSURE PROTOCOL - STAFF DO NOT GO TO EMERGENCY DEPARTMENT FOR TREATMENT - FOLLOW PROTOCOL BELOW Position/Job: All staff involved in caring for patients under investigation, as well as probable and confirmed cases of EVD or working in these areas. Potential Hazards: Exposure to EVD via blood/body fluids either percutaneous or mucu-cutaneous (i.e. mucous membranes of the eyes, nose or mouth). Training and Proficiency: All staff must be trained in this safe work procedure prior to assignment of caring for patients under investigation, as well as probable and confirmed cases of EVD. Training must be documented. Supervisors must ensure that workers are trained and follow this safe work procedure. Steps to be taken in the event of…… a percutaneous or muco-cutaneous (i.e., mucous membranes of the eyes, nose, or mouth) exposure to infectious material (blood, body fluids, secretions, or excretions) from a patient under investigation for EVD, or a patient with probable or confirmed EVD occurs. This safe work procedure must be made specific to the environment/facility, for example: the location of where first aid (wash/flush) takes place is dependent upon the location of equipment and cannot be performed in a contaminated area. The site OHN has the WORD document. 1 Immediately and safely stop any current tasks, leave the patient care area. 2 3 Remove all Personal Protective Equipment (PPE) as per the Removing PPE guidelines. Note: This must be done carefully because exposure during PPE removal can be just as dangerous for nosocomial transmission of EVD. If percutaneous, wash the affected skin surfaces of the percutaneous injury site with soap and water immediately after leaving the patient care area and removing PPE. If mucu-cutaneous (i.e. mucous membranes of the eyes, nose or mouth) irrigate mucous membranes (e.g., conjunctiva) with copious amounts of water or an eyewash solution. 4 Immediately report to Manager/Supervisor who will ensure the Source Risk Assessment and Source Testing are completed as per the Blood and Body Fluid Post Exposure Protocol. 5 Immediately report the incident to OESH by calling (204) 232-9075. This is a time-sensitive task and must be performed as soon as the healthcare worker leaves the patient care unit. Note: the incubation period begins two days following the exposure. Exposed persons will be medically evaluated by OESH including for other potential exposures (e.g., HIV, HCV) and receive followup care. OESH will consult with the Infectious Diseases (ID) specialist. Dependent upon the severity of the exposure, the ID Specialist will recommend one or a combination of the following: self monitoring, direct active monitoring, or restriction of activities/self isolation. Responsibilities 6 Managers/Supervisors: ensure all duties are performed in accordance to training, established health and safety and IP&C regulations/guidelines, policies and procedures (e.g. following safe work procedures) Staff performing task: perform task in accordance to training, established health and safety and IP&C regulations/guidelines, policies and procedures (e.g. following safe work procedures). Notify Manager or designates (i.e. supervisors) of all occurrences, injuries illnesses or safety and health concerns which are likely to harm themselves, co-workers, or any others who enter the premises. Completion and Review This safe work procedure will be reviewed any time the task, equipment or materials change and at a minimum of every three years from the last revision date Created/Completed Date: October 20, 2014 Last Revision Date: November 14, 2014 Created/Completed By: WRHA OESH & IP&C Last Revision By: WRHA OESH & IP&C OESH SWP EVD Blood Body Fluid Post Exposure Protocol References: WRHA IP&C EVD Operational Directive WRHA B/BF Post Exposure Protocol 2014.11.14 version 4